ArticleBMC public health2026
Exploring confusion with antibiotic identification at the community level in six low-and-middle-income countries across Asia and Africa.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundAntimicrobial resistance (AMR) is largely attributable to inappropriate antibiotic use particularly in low-and-middle-income countries (LMICs). Misidentification of antibiotics could contribute to inappropriate use, as people may use the wrong drugs for their conditions. Misidentification and inappropriate use are worsened by self medication and easy access to antibiotics that are obtained from unapproved sources, including over-the-counter medicine sellers. This study explored community perceptions of confusion with antibiotics identification and pathways to improve the identification through physical or visual appearance.
methodsA qualitative exploratory study was conducted from June 2021 and December 2022. A total of 140 In-depth interviews (IDIs) with medicine suppliers and 76 focus group discussions (FGDs) with community members were conducted in six countries spanning Africa (Ghana, Mozambique, South Africa) and Asia (Bangladesh, Thailand, Vietnam). Data was thematically analysed, and results presented as narratives with excerpts to support the findings.
resultsIdentification of antibiotics through physical and visual appearance emerged as a complex issue influenced by a variety of factors including colours, shapes, sizes, packaging, local terminologies, and cultural beliefs. Visual cues serve as a primary means of antibiotic identification across all studied countries. This is especially significant in contexts where language barriers or low literacy hinder identification by written labels. While there are common trends across the studied countries, such as the importance of colour in identification, there are also significant regional and local variations that should be considered. DISCUSSION: The study highlights visual cues a primary means of antibiotic identification, providing valuable insights for developing targeted health literacy and antibiotic awareness interventions. Ultimately, enhancing the ability of community members to accurately identify antibiotics is a key step in promoting responsible antibiotic use practices and improving global health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.